144 related articles for article (PubMed ID: 12845505)
1. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis.
Kungys G; Naujoks H; Wanner C
Eur J Clin Pharmacol; 2003 Aug; 59(4):291-5. PubMed ID: 12845505
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective pharmacokinetics of amlodipine in elderly hypertensive patients.
Ohmori M; Arakawa M; Harada K; Takasaki H; Hifumi S; Miyamori I; Fujimura A
Am J Ther; 2003; 10(1):29-31. PubMed ID: 12522517
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
Stangier J; Su CA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects.
Park JY; Kim KA; Park PW; Lee OJ; Kim JS; Lee GH; Ha MC; Park JH; O MJ; Ryu JH
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):641-7. PubMed ID: 17190374
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence study of generic amlodipine in healthy Thai male volunteers.
Rojanasthien N; Teekachunhatean S; Jakob K; Gaupp M; Arnold P; Chaichana N; Martin W
Int J Clin Pharmacol Ther; 2004 Jun; 42(6):330-5. PubMed ID: 15222726
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioequivalence study of a generic amlodipine tablet formulation in healthy male volunteers.
Sailer R; Arnold P; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(7):462-6. PubMed ID: 17803059
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine.
Vincent J; Harris SI; Foulds G; Dogolo LC; Willavize S; Friedman HL
Br J Clin Pharmacol; 2000 Nov; 50(5):455-63. PubMed ID: 11069440
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics and pharmacodynamics of amlodipine in hypertensive patients with and without type II diabetes mellitus.
Preston RA; Chung M; Gaffney M; Alonso A; Baltodano NM; Epstein M
J Clin Pharmacol; 2001 Nov; 41(11):1215-24. PubMed ID: 11697754
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of a single oral dose of two formulations of amlodipine. A randomized, single-blind, two-period, two-sequence, crossover study.
Pico JC; Domínguez G; Negri AL; Caubet JC; Terragno NA
Arzneimittelforschung; 2008; 58(7):323-7. PubMed ID: 18751497
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence study of an extemporaneously prepared oral solution of amlodipine suitable for use in pediatric patients compared to commercial tablets.
van der Vossen AC; van der Velde I; van den Meiracker AH; van der Nagel BC; Koch BC; Vulto AG; Hanff LM
Int J Clin Pharmacol Ther; 2016 Jan; 54(1):65-72. PubMed ID: 26558434
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
Yi S; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
J Cardiovasc Pharmacol; 2011 Jun; 57(6):682-9. PubMed ID: 21394036
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
Abernethy DR
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and dialysability of isradipine in chronic haemodialysis patients.
Schönholzer K; Marone C
Eur J Clin Pharmacol; 1992; 42(2):231-3. PubMed ID: 1535593
[TBL] [Abstract][Full Text] [Related]
17. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
18. Limited-sampling strategy models for estimating the area under the plasma concentration-time curve for amlodipine.
Suarez-Kurtz G; Vicente FL; Ponte CG; Buy VL; Struchiner CJ
Eur J Clin Pharmacol; 1999 Nov; 55(9):651-7. PubMed ID: 10638394
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral amlodipine orotate in vagotomized dogs.
Kwak HH; Kim JO; Chung HK; Choi SM; Kim JH; Kwon JW; Yoo M; Lee JH; Lee MG
Biopharm Drug Dispos; 2006 Apr; 27(3):141-5. PubMed ID: 16400620
[TBL] [Abstract][Full Text] [Related]
20. Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers.
Mignini F; Tomassoni D; Traini E; Amenta F
Clin Exp Hypertens; 2007 Nov; 29(8):539-52. PubMed ID: 18058479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
